That inconsistency complicates the interpretation of APOE’s quantitative effects in AD and has led to speculation that APOE RNA’s transcriptional/post-transcriptional modifications may contribute to these diverse observations across studies. The gene discussed is APOE; the disease is Alzheimer disease.